Stockscreener 앱 받기
6.035
0.50%
-0.025
전일 마감가:
$6.06
열려 있는:
$6.12
하루 거래량:
229.13K
Relative Volume:
0.80
시가총액:
$164.29M
수익:
$47.26M
순이익/손실:
$-58.48M
주가수익비율:
-2.2311
EPS:
-2.7049
순현금흐름:
$-40.45M
1주 성능:
-4.44%
1개월 성능:
-51.72%
6개월 성능:
-40.59%
1년 성능:
-58.95%
1일 변동 폭
$5.81
$6.183
1주일 범위
$5.81
$6.28
52주 변동 폭
$5.81
$18.55
Cvrx Inc Stock (CVRX) Company Profile
명칭
Cvrx Inc
전화
(763) 416-2850
주소
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
CVRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
6.035 | 164.29M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
131.85 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.17 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.86 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.53 | 106.51B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.57 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 재확인 | Lake Street | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2024-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Lake Street | Buy |
| 2022-07-18 | 개시 | Craig Hallum | Buy |
| 2021-07-26 | 개시 | Canaccord Genuity | Buy |
| 2021-07-26 | 개시 | Piper Sandler | Overweight |
| 2021-07-26 | 개시 | William Blair | Outperform |
모두보기
Cvrx Inc 주식(CVRX)의 최신 뉴스
CVRx, Inc. (NASDAQ:CVRX) Shares Sold by Alliancebernstein L.P. - Defense World
CVRx, Inc. (NASDAQ:CVRX) Shares Acquired by JPMorgan Chase & Co. - Defense World
CVRx, Inc. (NASDAQ:CVRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
(CVRX) Investment Analysis - news.stocktradersdaily.com
Cantor maintains CVRx stock with $20 target despite revenue miss By Investing.com - Investing.com India
Cantor maintains CVRx stock with $20 target despite revenue miss - Investing.com
William Blair Comments on CVRx’s Q1 Earnings (NASDAQ:CVRX) - Defense World
CVRx's SWOT analysis: barostim maker's stock faces growth hurdles By Investing.com - Investing.com India
CVRx stock slides on preliminary revenue miss - MSN
CVRx, Inc.: Overreaction Creates Buying Opportunity - Seeking Alpha
CVRx Insiders Lose Out As Stock Sinks To US$6.20 - simplywall.st
CVRx’s SWOT analysis: barostim maker’s stock faces growth hurdles By Investing.com - Investing.com India
CVRx's SWOT analysis: barostim maker's stock faces growth hurdles - Investing.com
Cantor Fitzgerald maintains CVRx stock Overweight rating By Investing.com - Investing.com South Africa
CVRx stock touches 52-week low at $6.36 amid market challenges By Investing.com - Investing.com South Africa
Top Midday Decliners - MarketScreener
CVRx stock drops on Q1 preliminary sales number miss - MassDevice
CVRx stock touches 52-week low at $6.36 amid market challenges - Investing.com
Cantor Fitzgerald maintains CVRx stock Overweight rating - Investing.com
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
CVRx price target lowered to $14 from $19 at Lake Street - TipRanks
Assessing CVRx: Insights From 4 Financial Analysts - Benzinga
Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Canaccord cuts CVRx stock target to $18, maintains Buy rating By Investing.com - Investing.com India
Top Premarket Decliners - MarketScreener
Canaccord cuts CVRx stock target to $18, maintains Buy rating - Investing.com
CVRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
CVRx (CVRX) Stock Drops as Preliminary Q1 2025 Revenue Disappoin - GuruFocus
CVRx stock slides on preliminary revenue miss (CVRX:NASDAQ) - Seeking Alpha
CVRx Sees Q1 Higher Revenue YOY, Missing Consensus -- Shares Fall After Hours - MarketScreener
CVRx Reports Preliminary First Quarter 2025 Financial Results - The Manila Times
CVRx Posts Mixed Q1 Earnings: 15% Growth Meets Headwinds as Expansion Continues - Stock Titan
(CVRX) Long Term Investment Analysis - news.stocktradersdaily.com
Bank of New York Mellon Corp Increases Stake in CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx stock plunges 42% in wake of Q1 report, updated forecast - MSN
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Several Insiders Invested In CVRx Flagging Positive News - Yahoo
Cantor Fitzgerald maintains CVRx stock with $20 target By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains CVRx stock with $20 target - Investing.com
(CVRX) Trading Report - Stock Traders Daily
With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For - Simply Wall St
Power Shift 25: Medtech firm's new CEO looks to 'build a world-class team'Minneapolis / St. Paul Business Journal - Minneapolis / St. Paul Business Journal
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Analyzing Co-Diagnostics (NASDAQ:CODX) and CVRx (NASDAQ:CVRX) - Defense World
CVRx, Inc. (NASDAQ:CVRX) Short Interest Down 9.8% in January - Defense World
CVRx, Inc. SEC 10-K Report - TradingView
CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles - MSN
CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles By Investing.com - Investing.com UK
CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim - GlobeNewswire
Cvrx, Inc. Announces New Real-World Evidence Demonstrating Significant Reductions in Healthcare Utility with Barostim - Marketscreener.com
Cvrx Inc (CVRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cvrx Inc 주식 (CVRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER |
Nov 19 '24 |
Option Exercise |
5.14 |
2,500 |
12,852 |
3,305 |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER |
Nov 19 '24 |
Sale |
13.58 |
1,430 |
19,417 |
1,875 |
0.85%
0.85%
자본화:
|
볼륨(24시간):